MELK Antikörper (AA 637-651)
Kurzübersicht für MELK Antikörper (AA 637-651) (ABIN1844288)
Target
Alle MELK Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 637-651
-
Sequenz
- C-VYKRLVEDIL SSCKV
-
Aufreinigung
- Purified antibody
-
Immunogen
- Synthesized peptide of human MELK (AA: 637-651:C-VYKRLVEDILSSCKV).
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS with 0.05 % sodium azide and 0.5 % protein stabilizer.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
-
- MELK (Maternal Embryonic Leucine Zipper Kinase (MELK))
-
Andere Bezeichnung
- MELK
-
Hintergrund
- Maternal embryonic leucine-zipper kinase (MELK) is a key regulator of survival of stemlike GBM cells in vitro. MELK expression is increased in breast cancer tissue and this increase is also associated with poor patient survival, as predicted for a candidate oncogene.
-
Molekulargewicht
- 74.6 kDa
-
Gen-ID
- 9833
-
UniProt
- Q14680
Target
-